Customer Outcomes & Value Experiencing A New Monitoring Technology
NCT04262700 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170
Last updated 2020-09-09
Summary
To investigate whether novel insight features in new Blood Glucose Monitoring System (BGMs) can improve glycemic control.
Conditions
Interventions
- DEVICE
-
LifeScan's new BGMS
LifeScan new Blood Glucose Monitoring System (BGMS)
Sponsors & Collaborators
-
LifeScan Scotland Ltd
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-07
- Primary Completion
- 2020-10-01
- Completion
- 2020-10-01
- FDA Device
- Yes
Countries
- United Kingdom
Study Locations
More Related Trials
-
Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System
NCT07092761 ·Status: RECRUITING ·Phase: NA
-
A User Performance and System Use Evaluation of a New Blood Glucose Monitoring System ( BGMS)
NCT03851549 ·Status: UNKNOWN ·Phase: NA
-
Project EV Minus Regulatory Clinical Evaluation - System Accuracy, User Performance and System Use Evaluation
NCT02718703 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes
NCT02082184 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study of the C8 MediSensors Optical Glucose Monitor™
NCT01726114 ·Status: COMPLETED ·Phase: NA
-
Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus
NCT01627184 ·Status: COMPLETED
-
Improving Glycemic Control on GMS: A Quality Improvement Study
NCT00271700 ·Status: COMPLETED ·Phase: NA
-
Evaluation of an Investigational Blood Glucose Monitoring System
NCT01859494 ·Status: COMPLETED ·Phase: NA
-
System Accuracy Evaluation of 2 CE-marked Blood Glucose Monitoring System
NCT02710617 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Blood Glucose Monitoring Systems
NCT01699763 ·Status: COMPLETED ·Phase: NA
-
System Accuracy of 12 Bloog Glucose Monitoring Systems
NCT05219526 ·Status: COMPLETED ·Phase: NA
-
Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device and Evaluation of the Instructions for Use
NCT04033042 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System
NCT04645641 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring System
NCT02880267 ·Status: COMPLETED ·Phase: NA
-
System Accuracy Evaluation of 6 CE-marked Blood Glucose Monitoring System Following ISO 15197:2013
NCT02531386 ·Status: COMPLETED ·Phase: NA
-
Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)
NCT06272136 ·Status: RECRUITING ·Phase: NA
-
Study of a Non-invasive Glucose Measuring Device
NCT05851469 ·Status: COMPLETED ·Phase: NA
-
System Accuracy and User Performance of Blood Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus
NCT02290067 ·Status: COMPLETED ·Phase: NA
-
Performance Evaluation of an Investigational Blood Glucose Monitoring System
NCT01598610 ·Status: COMPLETED ·Phase: NA
-
A Study of Non-invasive Measurement of Blood Glucose and Blood Pressure
NCT05904769 ·Status: TERMINATED ·Phase: NA
-
Effect of "Therapeutic Monitoring" on Blood Glucose Control in Type 2 Diabetes
NCT04164784 ·Status: UNKNOWN ·Phase: NA
-
Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance Education and Glycaemic Control
NCT01214824 ·Status: COMPLETED ·Phase: NA
-
Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes
NCT00202033 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating System Accuracy and User Performance of Omnitest® Blood Glucose Monitoring Systems for Self-testing in Managing Diabetes Mellitus
NCT02439177 ·Status: TERMINATED ·Phase: NA
-
Assessment of Blood Glucose Monitoring Systems
NCT01909687 ·Status: COMPLETED ·Phase: NA